Literature DB >> 16359402

Emergence of W135 meningococcal meningitis in Ghana.

Abudulai Adams Forgor1, Julia Leimkugel, Abraham Hodgson, Akalifa Bugri, Jean-Pierre Dangy, Sébastien Gagneux, Tom Smith, Gerd Pluschke.   

Abstract

Neisseria meningitidis serogroup W135, well known for a long time as a cause of isolated cases of meningococcal meningitis, has recently increasingly been associated with disease outbreaks of considerable magnitude. Burkina Faso was hit by W135 epidemics in the dry seasons of 2002-2004, but only four W135 meningitis cases were recorded between February 2003 and March 2004 in adjoining Ghana. This reconfirms previous findings that bottlenecks exist in the spreading of new epidemic N. meningitidis clones within the meningitis belt of sub-Saharan Africa. Of the four Ghanaian W135 meningitis patients one died and three survived, of whom one had profound neurosensory hearing loss and speech impairment. All four disease isolates were sensitive to penicillin G, chloramphenicol, ciprofloxacin and cefotaxime and had the multi-locus sequence type (ST) 11, which is the major ST of the ET-37 clonal complex. Pulsed-field gel electrophoresis (PFGE) profiles of the Ghanaian disease isolates and recent epidemic isolates from Burkina Faso were largely identical. We conducted meningococcal colonization surveys in the home communities of three of the patients and in the Kassena Nankana District located at the border to Burkina Faso. W135 carriage rates ranged between 0% and 17.5%. When three consecutive surveys were conducted in the patient community with the highest carrier rate, persistence of W135 colonization over a period of 1 year was observed. Differences in PFGE profiles of carrier isolates taken at different times in the same patient community were indicative of rapid microevolution of the W135 bacteria, emphasizing the need for innovative fine typing methods to reveal the relationship between W135 isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359402     DOI: 10.1111/j.1365-3156.2005.01520.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  16 in total

1.  Maternal mortality decline in the Kassena-Nankana district of northern Ghana.

Authors:  Samuel Mills; John E Williams; George Wak; Abraham Hodgson
Journal:  Matern Child Health J       Date:  2007-10-23

2.  Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.

Authors:  Ana Belén Ibarz-Pavón; Luis Morais; Betuel Sigaúque; Inacio Mandomando; Quique Bassat; Ariel Nhacolo; Llorenç Quintó; Montse Soriano-Gabarró; Pedro L Alonso; Anna Roca
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

3.  Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.

Authors:  Rolando Pajon; Andrew M Fergus; Oliver Koeberling; Dominique A Caugant; Dan M Granoff
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

4.  Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana.

Authors:  Julia Leimkugel; Abraham Hodgson; Abudulai Adams Forgor; Valentin Pflüger; Jean-Pierre Dangy; Tom Smith; Mark Achtman; Sébastien Gagneux; Gerd Pluschke
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

5.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

6.  Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008.

Authors:  Denis Massenet; Jermias Inrombe; Dave Etienne Mevoula; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

7.  A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.

Authors:  Abraham Hodgson; Abudulai Adams Forgor; Daniel Chandramohan; Zarifah Reed; Fred Binka; Cornelia Bevilacqua; Dominique Boutriau; Brian Greenwood
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

8.  Neisseria meningitidis serogroup W, Burkina Faso, 2012.

Authors:  Jessica R MacNeil; Isaïe Medah; Daouda Koussoubé; Ryan T Novak; Amanda C Cohn; Fabien V K Diomandé; Denis Yelbeogo; Jean Ludovic Kambou; Tiga F Tarbangdo; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Cynthia Hatcher; Jeni Vuong; Leonard W Mayer; Mamoudou H Djingarey; Thomas A Clark; Nancy E Messonnier
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

9.  Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA).

Authors:  Omar Rossi; Luana Maggiore; Francesca Necchi; Oliver Koeberling; Calman A MacLennan; Allan Saul; Christiane Gerke
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

10.  Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Authors:  Fati Sidikou; Maman Zaneidou; Ibrahim Alkassoum; Stephanie Schwartz; Bassira Issaka; Ricardo Obama; Clement Lingani; Ashley Tate; Flavien Ake; Souleymane Sakande; Sani Ousmane; Jibir Zanguina; Issaka Seidou; Innocent Nzeyimana; Didier Mounkoro; Oubote Abodji; Xin Wang; Muhamed-Kheir Taha; Jean Paul Moulia-Pelat; Assimawe Pana; Goumbi Kadade; Olivier Ronveaux; Ryan Novak; Odile Ouwe Missi Oukem-Boyer; Sarah Meyer
Journal:  Lancet Infect Dis       Date:  2016-08-23       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.